S.C. Schubert 1,3 , J.B. Trojanek 1,3 , S. Diemer 1,3 , A. Cobos 2,3 , Z. Zhou 1 , D.A. Treis 1 , L. Dai 1 , J. Schatterny 1 , S. Hirtz 1 , C. Schultz 2,3 , M.A. Mall 1,3 . 1 Ped. Pulmonology and CF Center, Dept. of Pediatrics III, University of Heidelberg, Heidelberg, Germany; 2 Dept. of Cell Biology and Biophysics, EMBL, Heidelberg, Germany; 3 
EMBL-University of Heidelberg Molecular Medicine Partnership Unit, Heidelberg, Germany
Previous studies demonstrated that increased airway Na + absorption and airway surface liquid (ASL) depletion in bENaC-overexpressing (bENaC-Tg) mice cause CF-like lung disease with airway mucus obstruction, chronic airway inflammation and emphysema. The goal of this study was to elucidate the mechanisms underlying emphysema formation in this murine model of CF lung disease. Because protease/antiprotease imbalance has been implicated as an important mechanism in emphysema pathogenesis, we first determined mRNA levels of proteases (matrix metalloproteinases [MMPs], cathepsins, neutrophil elastase) and antiproteases (TIMP1, SLPI, a1-AT) by real-time RT-PCR demonstrating a marked and exclusive increase of MMP-12 (also called macrophage elastase) expression in lungs from bENaC-Tg mice compared to littermates. Second, by using novel MMP-12 specific fluorescent resonance energy transfer (FRET) sensors, we demonstrate that MMP-12 activity was significantly elevated on alveolar macrophages from bENaC-Tg mice. To define the role of MMP-12 in emphysema formation we crossed bENaC-Tg mice with MMP-12 deficient mice and found that bENaC-Tg mice lacking MMP-12 (bENaC-Tg mice; MMP-12 −/ − ) were protected from distal airspace enlargement.
Our results indicate that ASL depletion leads to macrophage activation and MMP-12 secretion and identify MMP-12 as cause of emphysema in bENaC-Tg mice. Further studies are required to determine the role of MMP-12 in CF patients. Supported by EC (MEXT-CT-2004-013666).
214 Increased susceptibility to allergic airway inflammation in a murine model of cystic fibrosis lung disease Recent studies demonstrated that juvenile bENaC-Tg mice also exhibit spontaneous allergic airway inflammation. We hypothesized that airway surface dehydration in bENaC-Tg mice causes increased susceptibility for allergic airway inflammation due to reduced pulmonary clearance of inhaled allergens. To test this hypothesis, we induced allergic airway inflammation by repeated intratracheal instillations of Aspergillus fumigatus extract (Af), i.e. natural aeroallergen, and compared total and differential cell counts in bronchoalveolar lavage, pulmonary IL-13 expression, and airway morphology in bENaC-Tg mice with wild-type littermates. We demonstrate that elevation of airway eosinophils and pulmonary IL-13 caused by intrapulmonary exposure to Af are significantly increased in bENaC-Tg mice compared to wildtype controls. Further, we show that genetic deletion of Stat6 critical for Th-2 signaling protects bENaC-Tg mice from airway eosinophilia, elevated IL-13, goblet cell metaplasia and airway mucus obstruction. Our studies demonstrate that airway surface dehydration, characteristic of CF airways, plays a critical role in the pathogenesis of Stat6-dependent allergic airway inflammation. These findings are consistent with a high incidence of allergic bronchopulmonary aspergillosis (ABPA) and confounding allergic airway inflammation in CF patients. Although many reports have showed oxidative stress markers and a decreased antioxidant capacity in CF airway lining fluid, few studies have focused on the intracellular oxidant/antioxidant balance. The aim of this work was to evaluate the oxidation status in the lung of CFTR-KO (CF) and wild-type (WT) mice at the cellular level and their capacity to respond in vivo to oxidative challenge. Intracellular levels of reactive oxygen species, lipid oxidation, GSH-peroxidase and SOD activities were found significantly increased in CF compared to WT. As PRDX6 is a major lung antioxidant and the main detoxification system for peroxidized phospholipid (PC-OOH), its expression was further investigated. Q-RT-PCR, immunoblot and immunohistochemistry analyses revealed that PRDX6 mRNA and protein levels are increased in CF compared to WT. To evaluate the ability of CF pulmonary cells to limit phospholipid peroxidation under oxidative stress, PC-OOH (by HPLC) and PRDX6 expression levels were evaluated in response to paraquat (PQ). PQ induced a dramatic PC-OOH increase and a marked decrease in PRDX6 expression in CF mice. 2D gels and mass spectrometry revealed different PRDX6 modifications in WT vs CF. These results highlight a dramatic modification of lung oxidant/antioxidant status, a vulnerability to oxidative insult in CF lungs and present PRDX6 as a key component in CF antioxidant failure. This impaired PC-OOH detoxification mechanism may lead to membrane dysfunction and activate redox-related signaling, contributing to an exaggerated inflammatory response in CF lung. Supported by: Vaincre la mucoviscidose.
